DK2091938T3 - Piperidinylaminopyridaziner og anvendelse deraf som hurtigt opløsende antagonister af dopamin-2-receptorer - Google Patents

Piperidinylaminopyridaziner og anvendelse deraf som hurtigt opløsende antagonister af dopamin-2-receptorer

Info

Publication number
DK2091938T3
DK2091938T3 DK07847833.6T DK07847833T DK2091938T3 DK 2091938 T3 DK2091938 T3 DK 2091938T3 DK 07847833 T DK07847833 T DK 07847833T DK 2091938 T3 DK2091938 T3 DK 2091938T3
Authority
DK
Denmark
Prior art keywords
piperidinylaminopyridazines
dopamine
antagonists
receptors
dissolving
Prior art date
Application number
DK07847833.6T
Other languages
English (en)
Inventor
Jose Ignacio Andres-Gil
Jose Manuel Bartolome-Nebreda
Gool Michiel Luc Maria Van
Gregor James Macdonald
Den Keybus Frans Alfons Maria Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37964744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2091938(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK2091938T3 publication Critical patent/DK2091938T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK07847833.6T 2006-12-08 2007-12-05 Piperidinylaminopyridaziner og anvendelse deraf som hurtigt opløsende antagonister af dopamin-2-receptorer DK2091938T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125685 2006-12-08
PCT/EP2007/063338 WO2008068277A1 (en) 2006-12-08 2007-12-05 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists

Publications (1)

Publication Number Publication Date
DK2091938T3 true DK2091938T3 (da) 2011-02-07

Family

ID=37964744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07847833.6T DK2091938T3 (da) 2006-12-08 2007-12-05 Piperidinylaminopyridaziner og anvendelse deraf som hurtigt opløsende antagonister af dopamin-2-receptorer

Country Status (29)

Country Link
US (1) US8466153B2 (da)
EP (1) EP2091938B1 (da)
JP (1) JP5255568B2 (da)
KR (1) KR101468384B1 (da)
CN (1) CN101547915B (da)
AR (1) AR064198A1 (da)
AT (1) ATE486070T1 (da)
AU (1) AU2007328897B2 (da)
BR (1) BRPI0720247A2 (da)
CA (1) CA2665924C (da)
CL (1) CL2007003556A1 (da)
CY (1) CY1112227T1 (da)
DE (1) DE602007010179D1 (da)
DK (1) DK2091938T3 (da)
EA (1) EA016654B1 (da)
ES (1) ES2354756T3 (da)
HK (1) HK1137434A1 (da)
IL (1) IL199076A (da)
JO (1) JO2642B1 (da)
MX (1) MX2009005983A (da)
MY (1) MY148772A (da)
NO (1) NO20092574L (da)
NZ (1) NZ576484A (da)
PL (1) PL2091938T3 (da)
PT (1) PT2091938E (da)
SI (1) SI2091938T1 (da)
TW (1) TWI433676B (da)
UA (1) UA98940C2 (da)
WO (1) WO2008068277A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
EP2148872A1 (en) * 2007-04-23 2010-02-03 Janssen Pharmaceutica, N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
KR101506156B1 (ko) * 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸
CN101663292A (zh) * 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2729313C (en) * 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
EA019048B1 (ru) * 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2341965C3 (de) 1973-08-20 1979-01-25 C.H. Boehringer Sohn, 6507 Ingelheim 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen
NO147672C (no) 1975-09-23 1983-05-25 Janssen Pharmaceutica Nv Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
US4197304A (en) 1975-09-23 1980-04-08 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
EG12406A (en) 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
DE3218482A1 (de) 1982-05-15 1983-11-17 Bayer Ag, 5090 Leverkusen Substituierte 5-trifluormethyl-1,3,4-thiadiazol-2-yloxyessigsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
MX173362B (es) 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
GB9216298D0 (en) 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
TW406075B (en) 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
US5753679A (en) 1995-05-10 1998-05-19 Hoffmann-La Roche Inc. Benzyl-piperidine derivatives
MY116093A (en) 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
JP2002536291A (ja) * 1997-08-15 2002-10-29 ファイザー・プロダクツ・インク 2−(4−アリール又はヘテロアリール−ピペラジン−1−イルメチル)−1h−インドール誘導体
KR100261139B1 (ko) 1998-01-16 2000-08-01 황준수 신규한 알릴티오피리다진 유도체 및 그의 제조방법
US7494999B2 (en) 2004-10-29 2009-02-24 Kalypsys, Inc Sulfonyl-substituted bicyclic compounds as modulators of PPAR
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
SI1379520T1 (sl) 2001-02-23 2006-08-31 Merck & Co Inc N-substituirani nonaril-heterociklicni NMDA/NR2B antagonisti
ES2319879T3 (es) 2001-10-09 2009-05-14 Kyorin Pharmaceutical Co., Ltd. 4-(2-furoil)aminopiperidinas novedosas, productos intermedios en la sintesis de las mismas, procedimiento para producir las mismas y uso medico de las mismas.
AU2002360561A1 (en) 2001-12-11 2003-06-23 Sepracor, Inc. 4-substituted piperidines, and methods of use thereof
CA2474322A1 (en) 2002-01-25 2003-07-31 Kylix Pharmaceuticals B.V. 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
MXPA04007612A (es) 2002-02-05 2004-11-10 Novo Nordisk As Aril- y heteroarilpiperazinas novedosas.
US7183276B2 (en) 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
SE0201544D0 (sv) 2002-05-17 2002-05-17 Biovitrum Ab Novel compounds and thier use
AU2003272892A1 (en) 2002-09-26 2004-04-19 Mandom Corporation Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
EP2325183A1 (en) 2003-05-08 2011-05-25 Kyorin Pharmaceutical Co., Ltd. 4-(2-Furoyl) Aminopiperidine compound useful as therapeutic agent for itching
WO2005005779A2 (en) 2003-07-14 2005-01-20 Genesis Mining Technologies (Pty) Ltd Dual retention cutting arrangement
CN100584831C (zh) 2003-07-29 2010-01-27 高点制药有限责任公司 哒嗪基-哌嗪类及其作为组胺h3受体配体的应用
EP1653969A4 (en) 2003-08-07 2006-12-20 Japan Tobacco Inc PYRROLO 1,2-B PYRIDAZINE DERIVATIVES
JP2007534740A (ja) 2004-04-28 2007-11-29 ファイザー・インク バソプレッシンV1a受容体の阻害剤としての3−ヘテロシクリル−4−フェニル−トリアゾール誘導体
RU2006146985A (ru) 2004-05-28 2008-07-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецепторов
AR051092A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
KR20080021082A (ko) 2005-06-20 2008-03-06 쉐링 코포레이션 히스타민 h3 길항제로서 유용한 피페리딘 유도체
JO2769B1 (en) * 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
WO2007130383A2 (en) 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
WO2008019967A2 (en) 2006-08-15 2008-02-21 F. Hoffmann-La Roche Ag Phenyl, pyridine and quinoline derivatives
US8058243B2 (en) 2006-10-13 2011-11-15 Hsc Research And Development Limited Partnership Method for treating a brain cancer with ifenprodil
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
EA019048B1 (ru) 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина

Also Published As

Publication number Publication date
PT2091938E (pt) 2011-01-20
KR101468384B1 (ko) 2014-12-03
AU2007328897A1 (en) 2008-06-12
EP2091938B1 (en) 2010-10-27
CN101547915A (zh) 2009-09-30
AR064198A1 (es) 2009-03-18
CA2665924C (en) 2014-08-12
WO2008068277A1 (en) 2008-06-12
TWI433676B (zh) 2014-04-11
PL2091938T3 (pl) 2011-04-29
ES2354756T3 (es) 2011-03-17
JP2010511673A (ja) 2010-04-15
NZ576484A (en) 2010-10-29
US20100076187A1 (en) 2010-03-25
ATE486070T1 (de) 2010-11-15
UA98940C2 (ru) 2012-07-10
SI2091938T1 (sl) 2011-02-28
KR20090089858A (ko) 2009-08-24
CL2007003556A1 (es) 2008-06-13
CY1112227T1 (el) 2015-12-09
EA200970553A1 (ru) 2009-10-30
JP5255568B2 (ja) 2013-08-07
IL199076A (en) 2012-12-31
HK1137434A1 (en) 2010-07-30
TW200831098A (en) 2008-08-01
DE602007010179D1 (de) 2010-12-09
EA016654B1 (ru) 2012-06-29
CA2665924A1 (en) 2008-06-12
AU2007328897B2 (en) 2013-01-10
JO2642B1 (en) 2012-06-17
CN101547915B (zh) 2013-08-21
MX2009005983A (es) 2009-06-16
NO20092574L (no) 2009-09-08
MY148772A (en) 2013-05-31
EP2091938A1 (en) 2009-08-26
BRPI0720247A2 (pt) 2013-12-31
US8466153B2 (en) 2013-06-18

Similar Documents

Publication Publication Date Title
DK1943242T3 (da) Piperidin-4-yl-pyridazin-3-ylamin-derivater som hurtigt opløsende antagonister af dopamin-2-receptorer
DK2049478T3 (da) Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf
DK1986650T3 (da) Manipulationssikre doserignsformer
DK1857457T3 (da) Benzimidazolderivat og dets anvendelse som All-receptor-antagonist
DK2094709T3 (da) Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
DK2092722T3 (da) VoIP-konference
DK1963369T3 (da) Il-21-antagonister
DE602007005189D1 (de) rung
ITMI20061568A1 (it) Protesi di spalla
ITVR20060060A1 (it) Struttura di seggiolone
DE502007001122D1 (de) Humeruskomponente
FI20065757A (fi) Beta-laktamaasin käyttö
DK2069310T3 (da) Sulfonylpyrazolin-1-carboxamidin-derivater som 5-HT6-antagonister
DK1978944T3 (da) Blød-gelatine-kapselformulering
DK2091938T3 (da) Piperidinylaminopyridaziner og anvendelse deraf som hurtigt opløsende antagonister af dopamin-2-receptorer
ATE530650T1 (de) Hochaffine antagonisten von elr-cxc-chemokinen
DK2188268T3 (da) Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonister
DE602007004823D1 (de) Zusammensetzungen zur insektenbekämpfung
ATE524972T1 (de) Poly-tlr-antagonist
FR2904208B1 (fr) Baignoire portable
FR2902643B1 (fr) Attelle
ES1062720Y (es) Cuna balancin
TH87409B (th) เก้าอี้
UA14841S (uk) Крісло
UA14525S (uk) Крісло